A new type of inspection introduced by Health Canada to ensure regulatory compliance for clinical trials of drugs, vaccines and medical devices for COVID-19 has drawn positive feedback and could potentially be used for other types of studies.
Compliance readiness inspections (CRIs) were rolled out in October 2020 to streamline the conduct of COVID-19 trials and they have...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?